Capuano, I.; Buonanno, P.; Riccio, E.; Bianco, A.; Pisani, A.
Randomized Controlled Trials on Renin Angiotensin Aldosterone System Inhibitors in Chronic Kidney Disease Stages 3–5: Are They Robust? A Fragility Index Analysis. J. Clin. Med. 2022, 11, 6184.
https://doi.org/10.3390/jcm11206184
AMA Style
Capuano I, Buonanno P, Riccio E, Bianco A, Pisani A.
Randomized Controlled Trials on Renin Angiotensin Aldosterone System Inhibitors in Chronic Kidney Disease Stages 3–5: Are They Robust? A Fragility Index Analysis. Journal of Clinical Medicine. 2022; 11(20):6184.
https://doi.org/10.3390/jcm11206184
Chicago/Turabian Style
Capuano, Ivana, Pasquale Buonanno, Eleonora Riccio, Antonio Bianco, and Antonio Pisani.
2022. "Randomized Controlled Trials on Renin Angiotensin Aldosterone System Inhibitors in Chronic Kidney Disease Stages 3–5: Are They Robust? A Fragility Index Analysis" Journal of Clinical Medicine 11, no. 20: 6184.
https://doi.org/10.3390/jcm11206184
APA Style
Capuano, I., Buonanno, P., Riccio, E., Bianco, A., & Pisani, A.
(2022). Randomized Controlled Trials on Renin Angiotensin Aldosterone System Inhibitors in Chronic Kidney Disease Stages 3–5: Are They Robust? A Fragility Index Analysis. Journal of Clinical Medicine, 11(20), 6184.
https://doi.org/10.3390/jcm11206184